After partnering with four of the largest pharmaceutical companies over the past 18 months, Innovent Biologics is turning to a smaller partner for its next bet.
After partnering with four of the largest pharmaceutical companies over the past 18 months, Innovent Biologics is turning to a smaller partner for its next …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Innovent Biologics and Pfizer have entered a global partnership to develop 12 early-stage oncology programs. The deal includes a…
Despite its massive $10.5 billion size and 12-drug scope, Pfizer’s onc | Despite its massive $10.5 billion size and 12-drug…
On the eve of this year’s ASCO annual meeting, Pfizer said it is teaming up with China’s Innovent Biologics to advance a…
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to…
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
